Thank you | Patsnap

Product
- AI AGENTS
  
  Patsnap Eureka Platform
  
  Patsnap Eureka IP
  
  Patsnap Eureka Materials
- AI APPLICATIONS
  
  Analytics
  IP Intelligence
  
  Synapse
  Biopharma Intelligence
  
  Bio
  Biosequence Search and Analysis
  
  Chemical
  Chemical Structure Search and Analysis
- OTHERS
  
  Open Platform
  Data and APIs
  
  Professional Services
Solutions
- Law Firms
- Life Sciences
- High-Tech
Pricing
Resources
- EXPLORE
  
  Customer Stories
  
  Blog
  
  Global Innovation Report
  
  Glossary
- ENGAGE
  
  Webinars & Training
  
  Frontier
  
  User Community
- SUPPORT & SERVICES
  
  Trust and Security
  
  PatentBench
  
  LLM
  
  Help center
  
  Careers
About

Language
- Japanese

Login

Thanks for your interest in Patsnap!

A member of our team will respond to you within two business days.

In the meantime, you may be interested in:

Reviewing 2025: The Year Global Innovation Rewired Itself with Domain Specific AI

Category: Article

Tuesday, December 30, 2025

2025 marked a decisive shift in how the world innovates. R&D investment reached new highs, competition intensified across nearly every technology domain, and the gap widened between companies that successfully integrated AI into their workflows and those that struggled to keep pace.

Patsnap Spotlight: The Minds Behind Our AI Agents

Category: Article | Category: Video

Tuesday, December 23, 2025

In the latest episode of Patsnap Spotlight, we meet Jerald Han, an NLP Engineer who offers a behind-the-scenes look at how our team designs and develops AI agents that power innovation for IP and R&D professionals worldwide.

GLP-1R Race in 2025: 8 Essential Takeaways Drug Developers Need to Know

Category: Article

Tuesday, December 16, 2025

In late 2025, a seemingly narrow advertising dispute told a much bigger story about the GLP-1 market. Novo Nordisk’s challenge to Regen Doctors’ promotional claims for compounded semaglutide led the telehealth clinic to voluntarily withdraw its superiority and safety claims.